Abstract
Aim: To compare the audiometric thresholds and speech perception sentence test, between two groups with bilateral post-lingual, severe to profound sensorineural hearing loss.
Methods: Retrospective and analytical study, with 59 patients divided into 2 groups (under 60 years and above 60 years old) implanted between May/2002 and February/2007.
Results: The first group (control) included 30 patients with a mean age of 44 years. The audiometric threshold value in this group was 26 dB, and the average value of speech perception test was 94%. The second group included 29 patients with a mean age of 69 years. The average audiometric threshold was 29 dB, and the average value of SPT was 90%. The Mann-Whitney U-test was considered significant (P<0.05) only for 6-8 KHz frequencies and for SPT.
Conclusion: Both groups had excellent outcomes in audiometric and speech testing with the use of CI, but with a significantly better performance in the adult group
Keywords: Cochlear implants, elderly, speech test, rehabilitation of hearing impaired.
Current Aging Science
Title:Evaluation of Audiometric Thresholds and Speech Perception Sentence Test in Adults and Elderly After Cochlear Implantation
Volume: 9 Issue: 3
Author(s): Guilherme M. Carvalho, Mariana D.C. F. Santos, Henrique F. Pauna, Alexandre C. Guimarães, Silvia B. Curi, Daniele Jeronymo, Paulo R.C. Porto, Walter A. Bianchini, Arthur M. Castilho and Edi L. Sartorato
Affiliation:
Keywords: Cochlear implants, elderly, speech test, rehabilitation of hearing impaired.
Abstract: Aim: To compare the audiometric thresholds and speech perception sentence test, between two groups with bilateral post-lingual, severe to profound sensorineural hearing loss.
Methods: Retrospective and analytical study, with 59 patients divided into 2 groups (under 60 years and above 60 years old) implanted between May/2002 and February/2007.
Results: The first group (control) included 30 patients with a mean age of 44 years. The audiometric threshold value in this group was 26 dB, and the average value of speech perception test was 94%. The second group included 29 patients with a mean age of 69 years. The average audiometric threshold was 29 dB, and the average value of SPT was 90%. The Mann-Whitney U-test was considered significant (P<0.05) only for 6-8 KHz frequencies and for SPT.
Conclusion: Both groups had excellent outcomes in audiometric and speech testing with the use of CI, but with a significantly better performance in the adult group
Export Options
About this article
Cite this article as:
Carvalho M. Guilherme, Santos D.C. F. Mariana, Pauna F. Henrique, Guimarães C. Alexandre, Curi B. Silvia, Jeronymo Daniele, Porto R.C. Paulo, Bianchini A. Walter, Castilho M. Arthur and Sartorato L. Edi, Evaluation of Audiometric Thresholds and Speech Perception Sentence Test in Adults and Elderly After Cochlear Implantation, Current Aging Science 2016; 9 (3) . https://dx.doi.org/10.2174/1874609809666160322142817
DOI https://dx.doi.org/10.2174/1874609809666160322142817 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections:
Recent Patents on Regenerative Medicine Novel Synthetic Compounds as Potential Anticryptococcal Agents
Current Organic Synthesis The Extracellular Bacterial HtrA Proteins as Potential Therapeutic Targets and Vaccine Candidates
Current Medicinal Chemistry New Aspects of Integrin-mediated Leukocyte Adhesion in Inflammation: Regulation by Haemostatic Factors and Bacterial Products
Current Molecular Medicine Pharmacokinetics of Antifungal Agents in Neonates and Young Infants
Current Medicinal Chemistry The Use of Interferon-Gamma Therapy in Chronic Granulomatous Disease
Recent Patents on Anti-Infective Drug Discovery The Journey of the Non-Vascular Relief for Migraine: From ‘Triptans’ To ‘Ditans’
Current Clinical Pharmacology Rho as a Target to Promote Repair: Translation to Clinical Studies with Cethrin
Current Pharmaceutical Design Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications
Current Pharmaceutical Design Synthesis and Biological Activities of New Halophenols
Medicinal Chemistry Classical Neurotransmitters and Neuropeptides Involved in Parkinson's Disease: Focus on Anti-Parkinsonian Drugs
Current Drug Therapy Childhood Infectious Encephalitis: An Overview of Clinical Features, Investigations, Treatment, and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
CNS & Neurological Disorders - Drug Targets The Blood-Central Nervous System Barriers Actively Control Immune Cell Entry into the Central Nervous System
Current Pharmaceutical Design Altering the Tropism of Lentiviral Vectors through Pseudotyping
Current Gene Therapy Role of EGFR Inhibitors in the Treatment of Central Nervous System Metastases from Non-Small Cell Lung Cancer
Current Cancer Drug Targets Meningococcal Vaccines
Current Pharmaceutical Design Serial Extraction Technique of Rich Antibacterial Compounds in <i>Sargassum cristaefolium</i> Using Different Solvents and Testing their Activity
Current Bioactive Compounds Optimization of the Enzymolysis Conditions for Scorpion Peptides and Evaluation of its Antitumor Activity
Current Signal Transduction Therapy The Changing Face of HIV/AIDS in Treated Patients
Current HIV Research